Targeting cellular mRNAs translation by CRISPR-Cas9
暂无分享,去创建一个
Zhicong Chen | Weiren Huang | Yuchen Liu | Li Liu | C. Zhuang | Weiren Huang | Zhicong Chen | Yuchen Liu | Jianfa Li | Qiaoxia Zhang | Anbang He | Jianfa Li | Hanwei Wu | Yonghao Zhan | Li Liu | Chengle Zhuang | Junhao Lin | Qiaoxia Zhang | Y. Zhan | Anbang He | Hanwei Wu | Junhao Lin
[1] B. Graveley,et al. RNA-Guided RNA Cleavage by a CRISPR RNA-Cas Protein Complex , 2009, Cell.
[2] V. Iyer,et al. Efficient genome modification by CRISPR-Cas9 nickase with minimal off-target effects , 2014, Nature Methods.
[3] Jennifer A. Doudna,et al. Programmable RNA Tracking in Live Cells with CRISPR/Cas9 , 2016, Cell.
[4] David A. Scott,et al. Genome-wide binding of the CRISPR endonuclease Cas9 in mammalian cells , 2014, Nature Biotechnology.
[5] Lan Xu,et al. β3GnT8 regulates laryngeal carcinoma cell proliferation via targeting MMPs/TIMPs and TGF-β1. , 2012, Asian Pacific Journal of Cancer Prevention.
[6] Ralph Weissleder,et al. Visualization and tracking of tumour extracellular vesicle delivery and RNA translation using multiplexed reporters , 2015, Nature Communications.
[7] David A. Scott,et al. Double Nicking by RNA-Guided CRISPR Cas9 for Enhanced Genome Editing Specificity , 2013, Cell.
[8] Jin-Soo Kim,et al. Analysis of off-target effects of CRISPR/Cas-derived RNA-guided endonucleases and nickases , 2014, Genome research.
[9] Julia C. Engelmann,et al. siPools: highly complex but accurately defined siRNA pools eliminate off-target effects , 2014, Nucleic acids research.
[10] D. Liu,et al. Expression of β-catenin and cyclin D1 in epidermal stem cells of diabetic rats. , 2011, Molecular medicine reports.
[11] Benjamin L. Oakes,et al. Programmable RNA recognition and cleavage by CRISPR/Cas9 , 2014, Nature.
[12] Luke A. Gilbert,et al. Repurposing CRISPR as an RNA-Guided Platform for Sequence-Specific Control of Gene Expression , 2013, Cell.
[13] Lei Cao,et al. Osteopontin promotes a cancer stem cell-like phenotype in hepatocellular carcinoma cells via an integrin–NF-κB–HIF-1α pathway , 2015, Oncotarget.
[14] David S. Weiss,et al. Cas9-mediated targeting of viral RNA in eukaryotic cells , 2015, Proceedings of the National Academy of Sciences.
[15] Yunde Zhao,et al. Self-processing of ribozyme-flanked RNAs into guide RNAs in vitro and in vivo for CRISPR-mediated genome editing. , 2014, Journal of integrative plant biology.
[16] G. Church,et al. CAS9 transcriptional activators for target specificity screening and paired nickases for cooperative genome engineering , 2013, Nature Biotechnology.
[17] J. Doudna,et al. The new frontier of genome engineering with CRISPR-Cas9 , 2014, Science.
[18] M. Green,et al. Controlling gene expression in living cells through small molecule-RNA interactions. , 1998, Science.
[19] Lan Xu,et al. Down-regulation of β-1,3-N-acetylglucosaminyltransferase-8 by siRNA inhibits the growth of human gastric cancer. , 2011, Molecular medicine reports.
[20] Shiyou Zhu,et al. High-throughput screening of a CRISPR/Cas9 library for functional genomics in human cells , 2014, Nature.
[21] Christina D. Smolke,et al. Protein-responsive ribozyme switches in eukaryotic cells , 2014, Nucleic acids research.
[22] E. Lander,et al. Development and Applications of CRISPR-Cas9 for Genome Engineering , 2014, Cell.
[23] A. Fire,et al. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans , 1998, Nature.
[24] J. Joung,et al. High-fidelity CRISPR-Cas9 variants with undetectable genome-wide off-targets , 2015, Nature.
[25] Jay Shendure,et al. Saturation Editing of Genomic Regions by Multiplex Homology-Directed Repair , 2014, Nature.
[26] P. Schirmacher,et al. Human and mouse VEGFA-amplified hepatocellular carcinomas are highly sensitive to sorafenib treatment. , 2014, Cancer discovery.
[27] E Westhof,et al. Structural Basis of Ligand Discrimination by Two Related RNA Aptamers Resolved by NMR Spectroscopy , 1996, Science.
[28] C. Stein,et al. Intracellular mRNA cleavage induced through activation of RNase P by nuclease-resistant external guide sequences , 2000, Nature Biotechnology.
[29] Gang Wang,et al. Targeted and genome-wide sequencing reveal single nucleotide variations impacting specificity of Cas9 in human stem cells , 2014, Nature Communications.
[30] H. Jäckle,et al. Production of phenocopies by Krüppel antisense RNA injection into Drosophila embryos , 1985, Nature.
[31] David A. Scott,et al. Rationally engineered Cas9 nucleases with improved specificity , 2015, Science.
[32] J. Doudna,et al. Expanding the Biologist's Toolkit with CRISPR-Cas9. , 2015, Molecular cell.
[33] J. Keith Joung,et al. High frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells , 2013, Nature Biotechnology.
[34] Meagan E. Sullender,et al. Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9 , 2015, Nature Biotechnology.
[35] J. Keith Joung,et al. Improving CRISPR-Cas nuclease specificity using truncated guide RNAs , 2014, Nature Biotechnology.
[36] Chad W. Euler,et al. Exploiting CRISPR-Cas nucleases to produce sequence-specific antimicrobials , 2014, Nature Biotechnology.
[37] O. Uhlenbeck,et al. Interaction of R17 coat protein with synthetic variants of its ribonucleic acid binding site. , 1983, Biochemistry.
[38] Barbara Fink,et al. Conditional gene expression by controlling translation with tetracycline-binding aptamers. , 2003, Nucleic acids research.
[39] Jennifer A. Doudna,et al. DNA interrogation by the CRISPR RNA-guided endonuclease Cas9 , 2014, Nature.
[40] R. Barrangou,et al. Advances in CRISPR-Cas9 genome engineering: lessons learned from RNA interference , 2015, Nucleic acids research.
[41] Luke A. Gilbert,et al. Engineering Complex Synthetic Transcriptional Programs with CRISPR RNA Scaffolds , 2015, Cell.